Rich Erickson

Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer’s disease

Gai Ayalon, Seung-Hye Lee, Oskar Adolfsson et al. · Science Translational Medicine · 2021 · 111 citations · Full text

Life Sciences, Neurology, Neuroscience +16

A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes

EG Stefanich, H Wang, S. O’Byrne et al. · British Journal of Pharmacology · 2011 · 77 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma

Laura A Strickland, Jed Ross, Simon A. Williams et al. · The Journal of Pathology · 2009 · 71 citations

Medicine, Oncology, Pathology +14

Randomized Phase I Healthy Volunteer Study of <scp>UTTR</scp>1147A (<scp>IL</scp>‐22Fc): A Potential Therapy for Epithelial Injury

Michael E. Rothenberg, Yehong Wang, Annemarie Lekkerkerker et al. · Clinical Pharmacology & Therapeutics · 2018 · 67 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Molecular Characterization of Autosomal Recessive Chronic Granulomatous Disease Caused by a Defect of the Nicotinamide Adenine Dinucleotide Phosphate (Reduced Form) Oxidase Component p67-phox

Pablo Javier Patiño Grajales, Julie Rae, Deborah Noack et al. · Blood · 1999 · 65 citations

Life Sciences, Genetics, Molecular Genetics +14